Financial Performance - The company's revenue for Q1 2023 was ¥271,112,684.09, representing a 67.80% increase compared to ¥161,564,904.21 in the same period last year[5] - Net profit attributable to shareholders was ¥36,919,134.34, a significant increase of 486.13% from ¥6,298,759.91 year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥28,715,792.15, up 537.52% from ¥4,504,304.21 in the previous year[5] - Basic and diluted earnings per share increased to ¥0.08, a 300.00% rise from ¥0.02 in the previous year[5] - Operating profit for Q1 2023 was ¥44,968,114.46, compared to ¥7,446,179.80 in Q1 2022, indicating a substantial improvement[19] - The company reported a net profit of ¥44,968,114.46 for Q1 2023, a significant increase compared to the previous year's profit of ¥7,446,179.80[19] - In Q1 2023, Huarong Chemical reported a net profit of CNY 36,919,134.34, a significant increase from CNY 6,298,759.91 in the same period last year, representing a growth of approximately 484%[20] Cash Flow - The net cash flow from operating activities was ¥7,030,970.34, a turnaround from a negative cash flow of ¥36,640,674.50 in the same period last year, marking a 119.19% improvement[5] - Cash generated from operating activities improved by 119.19% to CNY 7,030,970.34, reflecting increased sales and collections[10] - Total cash inflow from operating activities reached CNY 272,958,845.92, compared to CNY 179,984,641.31 in the previous year, indicating a year-over-year increase of about 51.7%[23] - Cash flow from investing activities was CNY 295,495,911.06, a 288.32% increase due to net recoveries from structured deposits and interest[10] - Cash flow from investment activities showed a net inflow of CNY 295,495,911.06, a turnaround from a net outflow of CNY -156,912,280.50 in the same quarter last year[23] - The company recorded cash and cash equivalents at the end of Q1 2023 amounting to CNY 775,000,596.78, down from CNY 1,009,330,737.93 at the end of Q1 2022[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,152,473,876.91, a decrease of 2.92% from ¥2,217,204,122.53 at the end of the previous year[5] - Total current assets decreased to ¥1,855,748,046.46 from ¥1,925,407,837.28, a decline of 3.6%[16] - Total liabilities decreased to ¥500,805,868.17 from ¥564,118,213.30, a reduction of 11.2%[17] - Non-current assets increased to ¥296,725,830.45 from ¥291,796,285.25, a growth of 1.5%[16] Operational Metrics - The company reported a 102.75% increase in inventory, reaching ¥94,848,494.20, due to increased production and procurement of potassium chloride[9] - Accounts receivable rose by 95.67% to ¥83,662,383.36, driven by increased business volume[9] - The company's operating costs increased by 52.14% to CNY 217,350,614.94 due to higher market demand and sales scale[10] - Total operating costs for Q1 2023 were ¥238,836,595.28, up 54.1% from ¥154,953,925.02 in Q1 2022[19] - Research and development expenses for Q1 2023 were ¥2,269,315.26, slightly down from ¥2,448,279.85 in Q1 2022[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 25,026[12] - The largest shareholder, New Hope Chemical Investment Co., Ltd., holds 71.63% of the shares, totaling 343,800,000 shares[12] Non-Recurring Gains and Expenses - The company recognized non-recurring gains totaling ¥8,203,342.19, primarily from government subsidies and fair value changes of financial assets[6] - Tax and additional charges rose by 156.68% to CNY 2,577,877.25, primarily due to increased VAT payments[10] - Management expenses surged by 113.47% to CNY 13,476,796.20, attributed to an increase in personnel and related compensation[10] - Financial expenses skyrocketed by 339.73% to CNY 1,679,574.55, mainly due to increased foreign exchange losses[10] - The company reported a significant increase in investment income by 998.53% to CNY 4,344,269.65 from structured deposit returns[10] Miscellaneous - The company plans to continue expanding its market presence and investing in new product development to sustain growth[9] - The company did not undergo an audit for the Q1 2023 report[25]
华融化学(301256) - 2023 Q1 - 季度财报